Bikash Verma, MD, DVM, is Chief Executive Officer & Chief Medical Officer at MedTherapy working on immunotherapy of cancer. Dr. Verma’s focus has been upon prevention, diagnosis, and treatment of cancer. As a physician-scientist, he worked at Harvard Medical School as medical director and faculty. Subsequently, he worked in clinical research and development at Novartis, GSK, Celyad and Aurora as medical director and CMO. He is specialized in immunology, immuno-oncology and preventive medicine which he accomplished through his post-doctoral, doctoral, and master's degrees and fellowships completed at University of Massachusetts and affiliated hospitals, University of Illinois, S Illinois University, Tufts University.